NDC 0409-1463 – Nalbuphine Hydrochloride

Nalbuphine Hydrochloride 10 mg/mL · Injection, Solution · Intramuscular, Intravenous, Subcutaneous

Human Prescription Drug 1 recall

Product NDC0409-1463

Product details

Brand name
Nalbuphine Hydrochloride
Generic name
Nalbuphine Hydrochloride
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intramuscular, Intravenous, Subcutaneous
Marketing category
ANDA · ANDA070914
Marketed since
June 27, 2008
Listing expires
December 31, 2027
Pharmacologic class
Opioid Agonist/Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Nalbuphine hydrochloride →

Package NDC codes (2)

Package NDCDescriptionSince
0409-1463-0110 AMPULE in 1 TRAY (0409-1463-01) / 1 mL in 1 AMPULE (0409-1463-71)Mar 31, 2005
0409-1463-4910 AMPULE in 1 TRAY (0409-1463-49) / 1 mL in 1 AMPULE (0409-1463-69)Jun 27, 2008

Recalls mentioning this NDC

Other Nalbuphine hydrochloride products